vs

Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and Paymentus Holdings, Inc. (PAY). Click either name above to swap in a different company.

Paymentus Holdings, Inc. is the larger business by last-quarter revenue ($330.5M vs $168.4M, roughly 2.0× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 28.1%). Over the past eight quarters, Paymentus Holdings, Inc.'s revenue compounded faster (33.7% CAGR vs 10.6%).

Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.

Paymentus Holdings, Inc. is a leading cloud-based bill payment and customer engagement technology provider. It offers integrated digital payment solutions, billing automation tools, and self-service portals for enterprises across utilities, financial services, government, healthcare, and telecommunications segments, primarily operating in the North American market.

ESPR vs PAY — Head-to-Head

Bigger by revenue
PAY
PAY
2.0× larger
PAY
$330.5M
$168.4M
ESPR
Growing faster (revenue YoY)
ESPR
ESPR
+115.6% gap
ESPR
143.7%
28.1%
PAY
Faster 2-yr revenue CAGR
PAY
PAY
Annualised
PAY
33.7%
10.6%
ESPR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ESPR
ESPR
PAY
PAY
Revenue
$168.4M
$330.5M
Net Profit
$20.7M
Gross Margin
25.4%
Operating Margin
50.6%
7.3%
Net Margin
6.3%
Revenue YoY
143.7%
28.1%
Net Profit YoY
57.2%
EPS (diluted)
$0.32
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ESPR
ESPR
PAY
PAY
Q4 25
$168.4M
$330.5M
Q3 25
$87.3M
$310.7M
Q2 25
$82.4M
$280.1M
Q1 25
$65.0M
$275.2M
Q4 24
$69.1M
$257.9M
Q3 24
$51.6M
$231.6M
Q2 24
$73.8M
$197.4M
Q1 24
$137.7M
$184.9M
Net Profit
ESPR
ESPR
PAY
PAY
Q4 25
$20.7M
Q3 25
$-31.3M
$17.7M
Q2 25
$-12.7M
$14.7M
Q1 25
$-40.5M
$13.8M
Q4 24
$13.1M
Q3 24
$-29.5M
$14.4M
Q2 24
$-61.9M
$9.4M
Q1 24
$61.0M
$7.2M
Gross Margin
ESPR
ESPR
PAY
PAY
Q4 25
25.4%
Q3 25
24.1%
Q2 25
25.5%
Q1 25
24.0%
Q4 24
25.6%
Q3 24
26.2%
Q2 24
29.8%
Q1 24
28.5%
Operating Margin
ESPR
ESPR
PAY
PAY
Q4 25
50.6%
7.3%
Q3 25
-11.4%
6.4%
Q2 25
8.6%
5.7%
Q1 25
-34.0%
5.7%
Q4 24
-6.4%
5.5%
Q3 24
-31.0%
5.2%
Q2 24
3.5%
5.2%
Q1 24
52.5%
4.5%
Net Margin
ESPR
ESPR
PAY
PAY
Q4 25
6.3%
Q3 25
-35.9%
5.7%
Q2 25
-15.4%
5.3%
Q1 25
-62.2%
5.0%
Q4 24
5.1%
Q3 24
-57.2%
6.2%
Q2 24
-83.9%
4.7%
Q1 24
44.3%
3.9%
EPS (diluted)
ESPR
ESPR
PAY
PAY
Q4 25
$0.32
$0.16
Q3 25
$-0.16
$0.14
Q2 25
$-0.06
$0.11
Q1 25
$-0.21
$0.11
Q4 24
$-0.14
$0.11
Q3 24
$-0.15
$0.11
Q2 24
$-0.33
$0.07
Q1 24
$0.34
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ESPR
ESPR
PAY
PAY
Cash + ST InvestmentsLiquidity on hand
$167.9M
$320.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$-302.0M
$560.4M
Total Assets
$465.9M
$667.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ESPR
ESPR
PAY
PAY
Q4 25
$167.9M
$320.9M
Q3 25
$92.4M
$287.9M
Q2 25
$86.1M
$266.4M
Q1 25
$114.6M
$245.8M
Q4 24
$144.8M
$205.9M
Q3 24
$144.7M
$187.5M
Q2 24
$189.3M
$188.8M
Q1 24
$226.6M
$180.1M
Stockholders' Equity
ESPR
ESPR
PAY
PAY
Q4 25
$-302.0M
$560.4M
Q3 25
$-451.4M
$537.4M
Q2 25
$-433.5M
$516.7M
Q1 25
$-426.2M
$500.4M
Q4 24
$-388.7M
$485.6M
Q3 24
$-370.2M
$468.8M
Q2 24
$-344.2M
$451.6M
Q1 24
$-294.3M
$439.4M
Total Assets
ESPR
ESPR
PAY
PAY
Q4 25
$465.9M
$667.9M
Q3 25
$364.0M
$644.4M
Q2 25
$347.1M
$609.5M
Q1 25
$324.0M
$590.9M
Q4 24
$343.8M
$576.2M
Q3 24
$314.1M
$552.9M
Q2 24
$352.3M
$527.7M
Q1 24
$373.1M
$514.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ESPR
ESPR
PAY
PAY
Operating Cash FlowLast quarter
$45.2M
$45.1M
Free Cash FlowOCF − Capex
$45.0M
FCF MarginFCF / Revenue
13.6%
Capex IntensityCapex / Revenue
0.0%
0.0%
Cash ConversionOCF / Net Profit
2.18×
TTM Free Cash FlowTrailing 4 quarters
$161.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ESPR
ESPR
PAY
PAY
Q4 25
$45.2M
$45.1M
Q3 25
$-4.3M
$35.1M
Q2 25
$-31.4M
$31.5M
Q1 25
$-22.6M
$50.4M
Q4 24
$-35.0M
$27.9M
Q3 24
$-35.3M
$6.7M
Q2 24
$-7.2M
$18.0M
Q1 24
$53.8M
$11.0M
Free Cash Flow
ESPR
ESPR
PAY
PAY
Q4 25
$45.0M
Q3 25
$35.0M
Q2 25
$31.4M
Q1 25
$50.4M
Q4 24
$27.8M
Q3 24
$-35.5M
$6.7M
Q2 24
$-7.3M
$17.8M
Q1 24
$53.8M
$10.8M
FCF Margin
ESPR
ESPR
PAY
PAY
Q4 25
13.6%
Q3 25
11.3%
Q2 25
11.2%
Q1 25
18.3%
Q4 24
10.8%
Q3 24
-68.7%
2.9%
Q2 24
-9.9%
9.0%
Q1 24
39.0%
5.9%
Capex Intensity
ESPR
ESPR
PAY
PAY
Q4 25
0.0%
0.0%
Q3 25
0.0%
0.0%
Q2 25
0.0%
0.0%
Q1 25
0.0%
0.0%
Q4 24
0.0%
0.0%
Q3 24
0.3%
0.0%
Q2 24
0.1%
0.1%
Q1 24
0.1%
0.1%
Cash Conversion
ESPR
ESPR
PAY
PAY
Q4 25
2.18×
Q3 25
1.98×
Q2 25
2.14×
Q1 25
3.65×
Q4 24
2.12×
Q3 24
0.47×
Q2 24
1.93×
Q1 24
0.88×
1.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ESPR
ESPR

Collaboration Revenue$124.7M74%
Products$43.7M26%

PAY
PAY

Payment Transaction Processing Revenue$326.9M99%
Other$3.5M1%

Related Comparisons